A股異動丨紅宇新材超跌反彈 股東低位增持
格隆匯12月16日丨11月底經歷了連續6個跌停的紅宇新材(300345.SZ)今日展開超跌反彈行情,現漲8.77%,報8.06元,總市值35.6億元。

此前在經歷了連續六日跌停後,紅宇新材11月27日公告,公司目前經營情況正常,近期公司經營情況及內外部經營環境未發生重大變化。股東任立軍27日通過集中競價交易方式已增持公司股份40萬股,且計劃未來10個交易日內繼續增持公司股份不低於100萬股。此舉有利於維護投資者信心。
然而值得注意的是,2017年度、2018年度公司連續兩個會計年度經審計淨利潤為虧損,根據《深圳證券交易所創業板股票上市規則》相關規定,若公司 2019 年度經審計淨利潤為虧損,公司股票將可能自公司2019年年度報告披露後被深圳證券交易所暫停上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.